Dry powder inhalers of gentamicin and leucine: formulation parameters, aerosol performance and in vitro toxicity on CuFi1 cells

2012 ◽  
Vol 426 (1-2) ◽  
pp. 100-107 ◽  
Author(s):  
R.P. Aquino ◽  
L. Prota ◽  
G. Auriemma ◽  
A. Santoro ◽  
T. Mencherini ◽  
...  
Keyword(s):  
In Vitro Toxicity ◽  
Dry Powder Inhalers ◽  
Dry Powder ◽  
Aerosol Performance ◽  
Formulation Parameters

scholarly journals Dry powder inhalers: An overview of the in vitro dissolution methodologies and their correlation with the biopharmaceutical aspects of the drug products

2018 ◽  
Vol 113 ◽  
pp. 18-28 ◽  
Author(s):  
Sitaram P. Velaga ◽  
Jelena Djuris ◽  
Sandra Cvijic ◽  
Stavroula Rozou ◽  
Paola Russo ◽  
...  
Keyword(s):  
In Vitro Dissolution ◽  
Dry Powder Inhalers ◽  
Dry Powder ◽  
Drug Products

scholarly journals Microparticulate/nanoparticulate powders of a novel Nrf2 activator and an aerosol performance enhancer for pulmonary delivery targeting the lung Nrf2/Keap-1 pathway

2016 ◽  
Vol 1 (1) ◽  
pp. 48-65 ◽  
Author(s):  
Priya Muralidharan ◽  
Don Hayes ◽  
Stephen M. Black ◽  
Heidi M. Mansour
Keyword(s):  
Solid State ◽  
Engineering Design ◽  
Physicochemical Characterization ◽  
Pulmonary Delivery ◽  
Dry Powder Inhalers ◽  
Particle Engineering ◽  
Aerosol Performance ◽  
Nrf2 Activator ◽  
Respirable Particle

Solid-state respirable particle engineering design, physicochemical characterization, & in vitro aerosolization of advanced microparticulate/nanoparticulate dry powder inhalers targeting the lung Nrf2/Keap-1 pathway.

scholarly journals In Vitro Considerations to Support Bioequivalence of Locally Acting Drugs in Dry Powder Inhalers for Lung Diseases

2009 ◽  
Vol 11 (3) ◽  
pp. 414-423 ◽  
Author(s):  
Sau Lawrence Lee ◽  
Wallace P. Adams ◽  
Bing V. Li ◽  
Dale P. Conner ◽  
Badrul A. Chowdhury ◽  
...  
Keyword(s):  
Lung Diseases ◽  
Dry Powder Inhalers ◽  
Dry Powder
Sign in / Sign up

Export Citation Format

Share Document